BIDU Medical's trading volume on February 19 was $362 million, ranking 332nd among U.S. stocks on that day.

K-LinePoet · 2026-02-23T12:31:35+00:00

On February 19, 2026, Becton, Dickinson and Company (BDX) had a trading volume of $362 million, down 26.16% from the previous day. The stock fell 0.11% on that day, with a 52-week decline of 19.81%. The company's financial report showed that for the first quarter of fiscal year 2026, revenue increased by 1.63% year-over-year, and net profit grew by 26.07%.

K-LinePoet

2026-02-23 12:31:35

Abstract generation in progress

On February 19, 2026, Becton Dickinson & Co. (BDX) had a trading volume of $362 million, ranking 332nd among U.S. stocks for the day, a decrease of 26.16% from yesterday. The trading volume was 1.9851 million shares.

On February 19, 2026, Becton Dickinson & Co. (BDX) declined 0.11%, closing at $182.47. The stock has increased 2.62% over the past five trading days, fallen 10.33% for the entire month of February, decreased 5.98% since the beginning of the year, and dropped 19.81% over the past 52 weeks.

*If the company has been listed for less than 52 weeks, the 52-week change is calculated from the listing date to the present (this also applies to companies listed for less than 1 month or fewer than 5 trading days).

Becton Dickinson & Co. (BDX)	Trading Volume / USD	Change from Yesterday	Volume
February 19, 2026	$362 million	-26.16%	1.9851 million
February 18, 2026	$490 million	23.62%	2.6962 million
February 17, 2026	$396 million	-29.21%	2.2379 million
February 13, 2026	$560 million	-62.16%	3.1675 million
February 12, 2026	$1.479 billion	39.08%	8.3028 million

Becton Dickinson & Co. released its Q1 FY2026 earnings report on February 9, 2026. For the period from October 1, 2025, to December 31, 2025, revenue was $5.252 billion, up 1.63% year-over-year, with a net profit of $382 million, an increase of 26.07% year-over-year.

BD Medical Technology Co., Ltd. was incorporated in November 1906 under the laws of New Jersey. The company is a global medical technology firm engaged in the development, manufacturing, and sales of a wide range of medical supplies, devices, laboratory equipment, and diagnostic products used by healthcare providers, physicians, life science researchers, clinical laboratories, the pharmaceutical industry, and the public. The company provides customer solutions focused on improving medication management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; enhancing drug delivery; assisting anesthesia care; strengthening infectious disease and cancer diagnostics; promoting cell research and applications; and supporting diabetes management.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.